Performance of Novel Bed Side Scores as Predictors of Hospital Outcome in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Among Women; Cohort Study

Assiut University

Status: Not yet enrolling

Conditions: COPD Exacerbation

Study type: Observational

Funder types: Other

Identifiers

NCT05370664

Mortality outcome in COPD

Details and patient eligibility

About

• Assess predictors of mortality in COPD exacerbation between men and women.
• Evaluate the clinical outcomes in acute exacerbation of COPD in women.
• Evaluate the validity of new scoring systems ( NIVO, DECAF, HACOR ) as a predictor for hospital outcome in acute exacerbation of COPD.
• Compare these new scoring system with the most widely used APACHE IV.
• Assessment of serum level of granulocyte colony stimulating factor ( GM-CSF) in detecting the severity of COPD exacerbation.

Enrollment: 203 estimated patients

Sex: All

Ages: 35+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with AECOPD leading to hypoxemia, hypercapnia and respiratory acidosis with pH < 7.35 and PaCO2 > 45 mm of Hg will be admitted to the respiratory intensive care unit (ICU) for NIV or the ward will be eligible for inclusion and not in need for mechanical ventilation

Exclusion criteria

• Requirement for emergency intubation.
• Other contraindications to NIPPV including cardiac or respiratory arrest; nonrespiratory organ failure (eg, severe encephalopathy, severe gastrointestinal bleeding, hemodynamic instability with or without unstable cardiac angina); facial surgery or trauma; upper-airway obstruction; inability to protect the airway and/or high risk of aspiration; and inability to clear secretions.(6)
• Age < 35 years.

Trial design

203 participants in 2 patient groups

Female COPD

Male COPD